The stock of Invacare Corporation (NYSE:IVC) is a huge mover today! About 108,807 shares traded hands. Invacare Corporation (NYSE:IVC) has declined 25.02% since April 5, 2016 and is downtrending. It has underperformed by 26.98% the S&P500.
The move comes after 9 months positive chart setup for the $329.38M company. It was reported on Nov, 7 by Barchart.com. We have $17.03 PT which if reached, will make NYSE:IVC worth $220.68M more.
According to Zacks Investment Research, “Invacare Corporation is the world’s leading manufacturer and distributor of non-acute health care products based upon its distribution channels, the breadth of its product line and sales. The company designs, manufactures and distributes an extensive line of health care products for the non-acute care environment including the home health care, retail and extended care markets. The company’s products are sold through its world-wide distribution network byits sales force, telemarketing employees and various organizations of independent manufacturer’s representatives.”
Insitutional Activity: The institutional sentiment decreased to 1.3 in Q2 2016. Its down 1.58, from 2.88 in 2016Q1. The ratio worsened, as 19 funds sold all Invacare Corporation shares owned while 35 reduced positions. 19 funds bought stakes while 51 increased positions. They now own 33.23 million shares or 3.41% more from 32.13 million shares in 2016Q1.
Thrivent Finance For Lutherans has invested 0% of its portfolio in Invacare Corporation (NYSE:IVC). Swiss State Bank has 53,600 shares for 0% of their US portfolio. Barrow Hanley Mewhinney & Strauss Limited has invested 0% of its portfolio in Invacare Corporation (NYSE:IVC). Cornerstone Capital Mgmt Lc reported 13,900 shares or 0% of all its holdings. Legal General Public Ltd Co owns 6,216 shares or 0% of their US portfolio. Millennium Management reported 1.25M shares or 0.03% of all its holdings. Jacobs Levy Equity Management accumulated 285,909 shares or 0.07% of the stock. Alphaone Inv Limited Liability Co accumulated 1.53% or 341,253 shares. Moreover, Bnp Paribas Arbitrage Sa has 0% invested in Invacare Corporation (NYSE:IVC) for 9,371 shares. Geode Cap Ltd Liability holds 0% of its portfolio in Invacare Corporation (NYSE:IVC) for 196,105 shares. The New York-based Qs has invested 0.02% in Invacare Corporation (NYSE:IVC). Ironwood Invest Mgmt Limited Com has 0.45% invested in the company for 49,090 shares. The Pennsylvania-based Schneider Cap Mgmt Corp has invested 0.33% in Invacare Corporation (NYSE:IVC). Guggenheim Ltd Co owns 145,883 shares or 0.01% of their US portfolio. Heartland holds 2.18% or 3.19 million shares in its portfolio.
Insider Transactions: Since May 17, 2016, the stock had 2 buys, and 2 selling transactions for $98,705 net activity. $3,874 worth of Invacare Corporation (NYSE:IVC) shares were sold by LaPorte Dale C. Monaghan Matthew E. also bought $99,000 worth of Invacare Corporation (NYSE:IVC) shares. The insider HARRIS C MARTIN sold 475 shares worth $5,458. Shah Baiju R. bought $9,037 worth of Invacare Corporation (NYSE:IVC) on Wednesday, November 2.
More notable recent Invacare Corporation (NYSE:IVC) news were published by: Crainscleveland.com which released: “FDA identifies more problems at Invacare Corp.” on January 24, 2016, also Businesswire.com with their article: “Invacare Corporation to Host Conference Call to Discuss Second Quarter 2016 …” published on July 14, 2016, Businesswire.com published: “Invacare Corporation to Provide Update on Business Transformation at Upcoming …” on September 12, 2016. More interesting news about Invacare Corporation (NYSE:IVC) were released by: Businesswire.com and their article: “Marc Gibeley Joins Board of Directors of Invacare Corporation” published on November 20, 2015 as well as Businesswire.com‘s news article titled: “Invacare Corporation Announces Sale of ProBasics Brand in Line with …” with publication date: September 30, 2016.
IVC Company Profile
Invacare Corporation, incorporated on March 23, 1971, is a maker and distributor for medical equipment used in non-acute care settings. The Company’s geographical divisions are Europe, North America and Asia/Pacific. The Firm makes and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Firm sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services in the United States, Europe, Canada, New Zealand, Australia and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.